- Updated: Use of Injectable CAB/RPV LA as Replacement ART in Virally Suppressed Adults (5/15/23)
- Topics, Trends & Updates for May (5/11/23)
- Updated: Second-Line ART After Treatment Failure or for Regimen Simplification (5/10/23)
- Updated: Immunizations recommendations -- MenB (5/9/23)
- Updated: Guidance: Addressing the Needs of Older Patients in HIV Care (5/5/23)
- Updated: ART Drug-Drug Interactions with lenacapavir (LEN) (4/26/23)
- Updated: Immunizations recommendations -- MenB, HBV, pneumococcal, and zoster (4/18/23)
- FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults (5/25/23)
- NYSDOH AI Dear Colleague Letter: New York State’s continued response to mpox (5/19/23)
- NYSDOH AI Health Advisory: Mpox Cases Associated with Person-to-Person Transmission (5/2/23)
- NYSDOH & NYCDOHMH Launch Mpox Vaccine Campaigns Urging Eligible New Yorkers to Prepare Now for a Healthy Summer (5/2/23)
- NYCDOHMH Dear Colleague: COVID-19 Vaccination Updates (4/21/23)
- FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines (4/18/23)
- NYSDOH AI & NYCDOHMH Mpox Dear Colleague Letter Announcing Spring and Summer Media Campaign (3/27/23)
- NYSDOH AI: Call for Abstracts: 2023 Ending the Epidemic Summit & World AIDS Day Events (6/1/23)
- FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder (5/23/23)
- NYS Medicaid Update Special Edition – Part Four: NYRx Pharmacy Benefit Transition (5/23/23)
- CEI Newsletter (5/23/23)
- AETC NCRC: May 2023 Monthly Update (5/17/23)
- NYSDOH AI Dear Colleague Letter: Transition of pharmacy benefits in the New York State Medicaid program from Managed Care to the new NY Medicaid Pharmacy Program (NYRx) (4/20/23)
- FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use (4/13/23)
The New York State Department of Health (NYSDOH) AIDS Institute (AI) Clinical Guidelines Program is a longstanding, collaborative effort of the AI Office of the Medical Director and the Johns Hopkins University School of Medicine, Division of Infectious Diseases.
The program produces and publishes evidence-based, state-of-the-art clinical practice guidelines that establish uniform standards of care for NYS to improve the health and well-being of all adults who receive prevention services or treatment for HIV, viral hepatitis, other sexually transmitted infections, and substance use disorders.
Learn more: